Drug class in one race
No discrete molecular target drugs for Atherosclerotic Cardiovascular Disease
3 tracked No discrete molecular target drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the No discrete molecular target page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
2 Phase 1/21 Phase 1
Head-to-head evidence: Adipose-derived MSC clusters (S.Biomedics) vs ALF201 · ALF201 vs BGC101 · Adipose-derived MSC clusters (S.Biomedics) vs BGC101